STAA catalysts

    Catalysts and events linked to STAA, newest first.

    STAA stock catalysts and risks

    Latest published review: 2026-10-20

    DevelopmentTransmission channelEvidenceCondition to watch
    Staar Surgical Rallies 8% Following Stifel Upgrade to Buy and $31 Target
    2026-09-30 · Up
    sell-side target upward revision driving momentum buyingStifel upgraded STAA to buy and raised PT to $31.Not recorded
    Staar Surgical Rallies 8% on Stifel Upgrade and Lens Demand Outlook
    2026-09-30 · Up
    analyst rating upgrade and H2 sales estimate upward revisionsStifel upgraded to buy with price target raised to $31 on higher H2 2026 lens salesNot recorded
    Staar Surgical Rallies 8% on Stifel Rating Upgrade and Higher Price Target
    2026-09-30 · Up
    sell-side analyst consensus target revision and commercial volume expectationsStifel upgraded STAA to buy with a $31 target, lifting shares 8%.Not recorded
    Staar Surgical Board Authorizes $50 Million Share Buyback Program
    2026-09-27 · Up
    open-market buyback execution reducing public float and signaling balance sheet confidenceSource reports Staar Surgical board authorized a $50 million share repurchase program.Not recorded
    Staar Surgical Board Authorizes $50 Million Share Repurchase Program
    2026-09-27 · Up
    float reduction and capital allocation supportSource explicitly confirms $50M buyback authorization and 7.5% stock reaction.Not recorded
    Staar Surgical initiates $50M share repurchase program, lifting stock 7.5%
    2026-09-27 · Up
    float reduction and direct EPS accretion via buyback executionSource notes Staar Surgical stock surged 7.5% on $50M buyback authorization.Not recorded
    Staar Surgical Rallies 7.5% Following Board Approval of $50 Million Buyback Program
    2026-09-27 · Up
    direct share count reduction via $50M open market repurchase authorizationBoard authorized $50M buyback program, stock surged 7.5%.Not recorded
    Staar Surgical Board Authorizes $50 Million Share Repurchase Program
    2026-09-27 · Up
    float reduction via open market share repurchasesStaar Surgical announced a $50 million share buyback program, causing the stock to surge 7.5%.Not recorded

    Do these developments change your position?

    Review STAA alongside your other holdings and identify which decision deserves attention first.

    Review your initial audit before choosing ongoing portfolio scanning at $79/month.

    DateCardAvg 5d

    See today's live cards

    Public pages are published 24 hours after the product shows them. Desk shows every catalyst, event and causal reading as it happens, mapped to your holdings.

    Open Desk — $399/month